Zhitong Finance App News, Dean Diagnosis (300244.SZ) released its 2023 annual report. During the reporting period, the company achieved revenue of 13.408 billion yuan, a year-on-year decrease of 33.89%. Achieved net profit of 307 million yuan attributable to shareholders of listed companies, a year-on-year decrease of 78.56%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 295 million yuan, a year-on-year decrease of 81.90%. Basic earnings per share were $0.4918. It is proposed to distribute a cash dividend of 0.60 yuan (tax included) for every 10 shares to all shareholders.

During the reporting period, the diagnostic service business achieved revenue of 5.187 billion yuan, an increase of 11.91% over the same level last year. Among them, ICL achieved revenue of 4.718 billion yuan, a year-on-year increase of 16.73% over the same caliber last year.